Brian Ritchie | IR, LifeSci Advisors |
Roger Crystal | CEO |
David O'Toole | CFO |
Brandon Folkes | Cantor Fitzgerald |
David Bautz | Zacks Investment Research |
Greetings, and welcome to the Opiant Pharmaceuticals First Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Brian Ritchie with LifeSci Advisors. Please go ahead, sir.
Thank you, operator and thank you all for joining us this afternoon.